Total variation based DCE-MRI decomposition by separating lesion from background for time-intensity curve estimation

2017 ◽  
Vol 44 (6) ◽  
pp. 2321-2331 ◽  
Author(s):  
Hui Liu ◽  
Yuanjie Zheng ◽  
Dong Liang ◽  
Pinpin Tang ◽  
Fuquan Ren ◽  
...  
2021 ◽  
pp. 733-742
Author(s):  
Yuhang Sun ◽  
Dongming Wei ◽  
Zhiming Cui ◽  
Yujia Zhou ◽  
Caiwen Jiang ◽  
...  

2015 ◽  
Vol 42 (6) ◽  
pp. 1497-1506 ◽  
Author(s):  
Christiaan van der Leij ◽  
Cristina Lavini ◽  
Marleen G.H. van de Sande ◽  
Marjolein J.H. de Hair ◽  
Christophe Wijffels ◽  
...  

2019 ◽  
Vol 70 (3) ◽  
pp. 254-263 ◽  
Author(s):  
Omar Ahmad Hassanien ◽  
Rasha T. Abouelkheir ◽  
Mohamed Ibrahim Abou El-Ghar ◽  
Manal Ezzat Badawy ◽  
Samir Abdel-hakim El Gamal ◽  
...  

Purpose The aim of study is to assess the role of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and correlation with tumour angiogenesis in evaluation of urinary bladder cancer. Material and Methods The study included 81 patients with recent presumed diagnosis of bladder tumour or who came for follow up after management of histopathologically proven bladder cancer. All had DCE-MRI with time–signal intensity curve. The radiologic results then correlated with the histopathologic results using both haematoxylin and eosin stain and immuno-histochemical staining for localization and evaluation of CD34 immunoreactivity as a detector for the microvessel density (MVD) and tumour angiogenesis. Results Seventy-one cases were pathologically proven to be malignant: 41 cases (58%) showed type III time–signal intensity curve (descending); 22 cases (31%) showed type II (plateau); and 8 cases (11%) showed type I (ascending) curve. The sensitivity of DCE-MRI in stage T1 bladder tumour was 80%; in stage T2, it was (90.9%); and in stage T3, it was (96.9%). Overall accuracy of DCE-MRI in tumour staging was 89.5% and P = .001 (significant). Values more than the cutoff value = 76.13 MVD are cystitis with sensitivity (90%), specificity (91%), and P value is .001, which is statistically highly significant. Conclusion There is a strong positive association between DCE-MRI (staging and washout slope of the time–signal intensity curve) with histopathologic grade, tumour stage, and MVD in bladder cancer. So, DCE-MRI can be used as reliable technique in preoperative predictions of tumour behavior and affect the planning of antiangiogenetic therapy.


2019 ◽  
Vol 45 (9) ◽  
pp. 2502-2514 ◽  
Author(s):  
Hanping Wu ◽  
Eric C. Abenojar ◽  
Reshani Perera ◽  
Al Christopher De Leon ◽  
Tianzhi An ◽  
...  

2014 ◽  
Vol 14 (S1) ◽  
Author(s):  
H Sherif ◽  
A Mahfouz ◽  
A Kambal ◽  
A Sayedin ◽  
I Mujeeb

2020 ◽  
Vol 2020 ◽  
pp. 1-12
Author(s):  
Xiaoling Leng ◽  
Guofu Huang ◽  
Lianhua Zhang ◽  
Jianbing Ding ◽  
Fucheng Ma

Nonluminal breast cancer has high early metastasis and treatment resistance, and neoadjuvant chemotherapy (NAC) is needed. The presence of cancer stem cells (CSC) and epithelial-mesenchymal transition (EMT) leads to poor prognosis. This study investigated the changes in CSC markers and EMT markers after NAC in nonluminal breast cancer and their correlation with contrast-enhanced ultrasound (CEUS) features and chemotherapy efficacy. Before NAC, the range of nonluminal breast cancer on CEUS was larger than that of two-dimensional ultrasound, but after NAC, it was significantly smaller than that of two-dimensional ultrasound and closer to the postoperative pathological size. After NAC, the enlarged lesions and perfusion defects were significantly less than those before NAC. The time-intensity curve showed the characteristics of slow-in, low enhancement, and low perfusion. Nonluminal breast cancer downregulated the expression of CSC markers and EMT markers after NAC, but the epithelial phenotype of nonluminal breast cancer with good response to chemotherapy was upregulated. In nonluminal breast cancer with poor response to chemotherapy, markers of CSC and EMT were highly expressed before chemotherapy. In conclusion, CEUS is better than conventional ultrasound in estimating NAC efficacy in this mode. CEUS can also predict the prognosis of nonluminal breast cancer before NAC with the characteristics of enhanced enlargement and perfusion defects. The contrast-enhanced time-intensity curve of lesions with relatively poor blood supply may have more CSC and EMT characteristics.


Sign in / Sign up

Export Citation Format

Share Document